Insider Activity Signals Confidence – but Not a Guarantee
On March 16, 2026, Chief Executive Officer Jiang Tianyi added 147 338 shares of AvePoint’s common stock to his holdings at an average price of $10.35, raising his total position to 2 299 627 shares. The move was executed just days after a series of routine equity‑award adjustments reported by several insiders, including Executive Chairman Gong Xunkai and CFO Caci James. Unlike the large block sales seen in late‑2025, Jiang’s purchase is modest in size—about 0.65 % of the company’s free‑float—and was completed at a price virtually unchanged from the close, suggesting a neutral market reaction. The filing’s sentiment score of zero and negligible social‑media buzz further indicate that investors are largely unreactive to this single trade.
What the Trade Means for Investors
The purchase comes at a time when AvePoint’s stock is trading near its 52‑week low of $9.86, yet still well above the 2025 low and below its 52‑week high of $20.25. A 2 % dip in the weekly price and a 31 % decline year‑to‑date have raised concerns about the company’s valuation, especially given a P/E ratio of nearly 70. Jiang’s buy, therefore, can be interpreted as a “sign‑off” from the CEO that the business fundamentals—particularly its SaaS migration platform—continue to justify the current price range. For long‑term investors, the move signals that management remains aligned with shareholders, which can be a positive signal in a market that has seen frequent insider sell‑offs. However, the modest size of the purchase limits its impact on the stock’s price or on market sentiment.
Jiang Tianyi’s Insider‑Trading Profile
Jiang’s insider‑trading history over the past 12 months shows a pattern of balanced buying and selling, with an overall net accumulation of shares. In March 2025, he sold over 1.5 million shares and bought back more than 2 million, ending the month with a larger stake. He has also exercised significant option activity, selling and buying options in large blocks that reflect his confidence in the company’s performance metrics. Importantly, Jiang’s trades are largely exempt under Rule 16b‑3, indicating that they are linked to vesting schedules or performance‑based equity awards rather than opportunistic speculation. This disciplined approach suggests that Jiang’s trades are driven by corporate governance and long‑term value creation rather than short‑term price moves.
Broader Insider Context
The March 13 filings from other executives show a mix of sales and purchases that net out to relatively small changes in holdings. Gong Xunkai sold a sizable block of shares but simultaneously acquired a larger block of common stock and options, keeping his net position stable. CFO Caci James’ trades largely involved selling and buying shares in near‑equal amounts. Together, these patterns reinforce a narrative that AvePoint’s leadership is actively managing their equity holdings in a way that aligns with the company’s long‑term goals, rather than engaging in high‑frequency trading that could alarm shareholders.
Looking Ahead
For investors assessing AvePoint, Jiang’s recent purchase adds a modest layer of confidence that the CEO believes in the company’s trajectory, especially as the stock recovers from its recent trough. Yet, the broader insider activity indicates a careful balancing act: executives are maintaining significant holdings while also participating in routine equity‑award adjustments. This duality suggests that management is neither overly aggressive nor excessively passive. As AvePoint continues to develop its SaaS solutions and navigates a competitive IT landscape, the insider transactions provide a useful, though not definitive, barometer of leadership sentiment.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-03-16 | Jiang Tianyi (Chief Executive Officer) | Buy | 147,338.00 | N/A | Common Stock |
| 2026-03-16 | Jiang Tianyi (Chief Executive Officer) | Buy | 252,609.00 | 10.52 | Stock Option (Right to Buy) |
| 2026-03-16 | Gong Xunkai (Executive Chairman) | Buy | 190,114.00 | N/A | Common Stock |
| 2026-03-16 | Gong Xunkai (Executive Chairman) | Buy | 325,947.00 | 10.52 | Stock Option (Right to Buy) |




